HMN 2025: How New B meningococcus vaccine reveals promise in early-stage trial
Health Medicine Network,
The final result of a trial revealed in Science Translational Medicine, reveals encouraging outcomes for a brand new vaccine…
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Overview of attention for article published in Science Translational Medicine, May 2025
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
Average Attention Score compared to outputs of the same age and source
Mentioned by
- news
- 3 news outlets
- blogs
- 1 blog
- policy
- 1 policy source
- 9 X users
- bluesky
- 3 Bluesky users
Readers on
- mendeley
- 9 Mendeley